Key result
A high-risk baseline clinical-biological score was associated with higher long-term mortality compared to a low-risk score following left atrial appendage closure.
Why the study?
Bleeding-prone conditions often drive referral for LAAC in AF patients unsuitable for anticoagulation, but their impact on procedural risk versus long-term vulnerability is unclear.
Cohort (n=747)
No
Answers are grounded in this paper and cite their sources.
In high-risk patients undergoing LAAC, bleeding-prone conditions do not increase procedural risk, whereas baseline clinical-biological markers strongly predict long-term mortality.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Massoullié et al. (2026) conducted a cohort in Atrial fibrillation unsuitable for long-term oral anticoagulation (n=747). High-risk baseline clinical-biological score vs. Low-risk baseline clinical-biological score was evaluated on All-cause mortality (HR 4.39, 95% CI 2.67-7.21, p=<0.001). A high-risk baseline clinical-biological score was associated with higher long-term mortality compared to a low-risk score following left atrial appendage closure.
Synapse has enriched 10 related papers. Consider them for comparative context: